Dr. Lichtenstein has a professional interest in inflammatory bowel disease, Crohn’s disease and ulcerative colitis. His research interests include medical therapy of IBD, safety of current medical therapy for IBD and natural history of disease.
Dr. Lichtenstein’s work has been published in professional journals and textbooks, such as Gastroenterology, Inflammatory Bowel Diseases and Medical Therapy of Ulcerative Colitis.
Dr. Lichtenstein earned his medical degree at Mount Sinai School of Medicine in New York and completed his residency at Duke University Medical Center in Durham, N.C. He completed his fellowship at the Hospital of the University of Pennsylvania.
More articles on GI/endoscopy:
The Johns Hopkins Hospital completes 1st MUSE procedures: 5 key facts
$43B by 2019: 6 key trends in the global endoscopy market
5 most read GI articles – April 20 to April 24
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.